Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_assertion type Assertion NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_head.
- NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_assertion description "[The discovery of the JAK2V617F mutation followed by the discovery of other genetic abnormalities allowed important progress in the understanding of the pathogenesis and management of myeloproliferative neoplasms (MPN)s. Classical Breakpoint cluster region-Abelson (BCR-ABL)-negative neoplasms include 3 main disorders: essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_provenance.
- NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_assertion evidence source_evidence_literature NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_provenance.
- NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_assertion SIO_000772 25486952 NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_provenance.
- NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_assertion wasDerivedFrom befree-2016 NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_provenance.
- NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_assertion wasGeneratedBy ECO_0000203 NP1246140.RA_gRRx2cGc6fnwZQFU1z3jHOpJmIq_iJEUsyq5TziSak130_provenance.